PHILADELPHIA, Oct. 22 -- Wolters Kluwer Health announced today a series of initiatives to bolster its CME organization andprograms for professionals and students in medicine, nursing, allied health and pharmacy. The company has made organizational enhancements following strict guidelines set by the Accreditation Council for Continuing Medical Education (ACCME) and appointed
LCMEI, which provides more education than any other nationally accredited publisher in the US, is part of Wolters Kluwer Health, Medical Research (Wolters Kluwer Health, Inc.), a global leader in providing innovative online research solutions for the medical, scientific and academic communities and medical journal publishing solutions for healthcare practitioners and educators. As part of its CME restructuring, Wolters Kluwer Health has separated LCMEI from any Wolters Kluwer legal entity that markets products or activities which are supported by or sold to a Commercial Interest, defined as any entity producing, marketing, reselling or distributing health care goods and services consumed by, or used on, patients. Wolters Kluwer will operate its commercial pharmaceutical related activities as Wolters Kluwer Pharma Solutions (Wolters Kluwer Pharma Solutions, Inc.).
“Wolters Kluwer Health is committed to connecting healthcare professionals and students with access to the most accurate, up-to-date and accessible information to help them stay abreast of industry advancements and make better decisions throughout their careers,” said Bob Becker, President & CEO of Wolters Kluwer Health & Pharma Solutions. “We have undertaken the initiative of introducing an organizational and legal separation between our Pharma Solutions and healthcare operations to ensure the continuation of the highest levels of integrity of our CME offering to our customers.”
In addition to the restructuring, LCMEI will now be overseen by Dr. Overstreet, a licensed pharmacist and adult educator who has been a leader in the CME community for 18 years. Dr. Overstreet brings a great deal of industry knowledge and expertise to her new role, having served on the Board of Directors of the Alliance for CME and currently serving as President of the National Commission for Certification of CME Professionals. She has received numerous awards for innovation, research and service to the medical education community and is recognized by the North American Association of Medical Education and Communication Companies as an Exemplary CME Professional.
“We are pleased to welcome Dr. Overstreet to Wolters Kluwer Health and look forward to working with her to take our CME program to the next level to make it even more valuable for our customers,” said Karen Abramson, President & CEO of Wolters Kluwer Health, Medical Research. “As the demand for instant information and content in the healthcare industry grows, LCMEI is planning exciting new tools and solutions to make our CME programs even more accessible to and cost-effective for our customers and to help our customers effectively apply data in practice.”
At LCMEI, Dr. Overstreet will be responsible for strategic planning, compliance and growth of the provider unit. She will have business development responsibilities and will oversee the facilitation of resource application and staff development. Dr. Overstreet holds a BS degree in pharmacy from the University of North Carolina, an MS degree in drug information and communication from Long Island University and an EdD degree in adult education from Temple University. She is a board-certified Editor in the Life Sciences and a Fellow of the Alliance for CME and was among the first cohorts to receive certification as a CME Professional. Dr. Overstreet will be based in Wolters Kluwer Health’s office in Philadelphia, Pa.
LCMEI develops and offers high quality CME activities to support healthcare professionals in practice-based learning and improvement. LCMEI provides valuable educational activities relevant to clinical practice in a variety of formats, including journals and journal supplements, newsletters, monographs, electronic media, textbooks and conferences, in a variety of therapeutic and specialty areas, including Anesthesiology, Emergency/Critical Care, Endocrinology, Family Practice, Gynecology, Infectious Diseases, Immunology, Neurosurgery, Nutrition, Obstetrics, Oncology, Ophthalmology, Orthopedics, Pain Management, Pediatrics, Psychiatry, Radiology, Surgery, Transplantation and Wound Care.
For more information visit LCMEI’s website at http://www.lww.com/resources/cmeinfo/index.html.
About Lippincott CME Institute (LCMEI)
LCMEI, a subsidiary company of Wolters Kluwer Health, is one of the few publishing companies in the world accredited to provide CE for both physicians and pharmacists. LCMEI is accredited by the Accreditation Council for Continuing Medical Education and the Accreditation Council for Pharmacy Education to provide certified continuing education.
LCMEI certifies CE activities for Wolters Kluwer Health products, including those developed by Lippincott Williams & Wilkins, Facts & Comparisons, and others.
About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of euro 3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.
SOURCE Wolters Kluwer Health
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All